Potassium Chloride Extended Release Tablet, Extended Release
Product Images NDC 16571-843

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Potassium Chloride Extended Release (NDC 16571-843). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10meq (Postassium Chloride 10meq 01)

Label for Potassium Chloride Extended-Release Tablets, USP 750 mg (10 mEq) by Rising Pharmaceuticals. The label indicates 100 tablets per package, with instructions on storage, dosage, and patient information. Manufactured for Rising Pharma Holdings, Inc., East Brunswick, NJ, made in India.*

FDA Label Image

8meq (Potassium Chloride 8meq 01)

Label for Potassium Chloride Extended-Release Tablets, USP 600 mg (8 mEq) by Rising Pharma Holdings, Inc. The label shows a package of 100 extended-release oral tablets, with storage, dosage, and safety information including child-resistant packaging. The product is manufactured in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.